InnoFluidics aims for decreasing the cancer burden by providing innovative technologies. We are building a microfluidics‐based platform for blood analysis of cancer patients. We are working towards delivering the best performing technology to the market.
We are developing a liquid biopsy platform relying on label‐free, fast, and sensitive electrical measurements for enumeration, purification, and collection of intact CTCs (circulating tumor cells) directly from patient blood. The platform operates as a sample‐in‐result‐out format: CTCs are detected, enumerated, purified, and collected in one go.